Truist Securities Reiterates Buy Rating on Nurix (NRIX)

October 1, 2024 1:44 PM EDT Send to a Friend
Truist Securities analyst Srikripa Devarakonda reiterated a Buy rating and $36.00 price target on Nurix (NASDAQ: NRIX).The analyst commented, "NRIX ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login